Centiva Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Centiva Capital’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$3.76M	–	2029
2022 Q2	$3.76M	Buy	+50,000	New	+$2.22M	0.09%	199
2021 Q2	–	Sell	-3,223	Closed	-$305K	–	1846
2021 Q1	$305K	Buy	+3,223	New	+$383K	0.01%	756
2020 Q3	–	Sell	-5,155	Closed	-$333K	–	926
2020 Q2	$333K	Buy	+5,155	New	+$297K	0.02%	387

Centiva Capital's TPTX Position: Q3 2022 in Review

Centiva Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 50,000 shares — an estimated $3.76M sold.

Centiva Capital first reported a position in TPTX in Q2 2020 and held it in 3 quarters. The position peaked at $3.76M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Centiva Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Centiva Capital sold 50,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $3.76M.
Centiva Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Centiva Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $3.76M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.